Article Versions Notes

Almehmadi M, Allahyani M, Alsaiari AA, Alshammari MK, Alharbi AS, Hussain KH, Alsubaihi LI, Kamal M, Alotaibi SS, Alotaibi AN, et al. A Glance at the Development and Patent Literature of Tecovirimat: The First-in-Class Therapy for Emerging Monkeypox Outbreak. Viruses. 2022; 14(9):1870. https://doi.org/10.3390/v14091870

Almehmadi, Mazen, Mamdouh Allahyani, Ahad Amer Alsaiari, Mohammed Kanan Alshammari, Abrar Saleh Alharbi, Khansa Hamza Hussain, Lojain Ibrahim Alsubaihi, Mehnaz Kamal, Shahad Saleh Alotaibi, Atheer Nasser Alotaibi, and et al. 2022. "A Glance at the Development and Patent Literature of Tecovirimat: The First-in-Class Therapy for Emerging Monkeypox Outbreak" Viruses 14, no. 9: 1870. https://doi.org/10.3390/v14091870

Almehmadi, M., Allahyani, M., Alsaiari, A. A., Alshammari, M. K., Alharbi, A. S., Hussain, K. H., Alsubaihi, L. I., Kamal, M., Alotaibi, S. S., Alotaibi, A. N., Aldhafeeri, A. A., & Imran, M. (2022). A Glance at the Development and Patent Literature of Tecovirimat: The First-in-Class Therapy for Emerging Monkeypox Outbreak. Viruses, 14(9), 1870. https://doi.org/10.3390/v14091870